首页 > 《岭南心血管病杂志：英文版》 > 2008年2期 > Inhibitory Effect of Clopidogrel on Release of Soluble CD40 Ligand by ADP-activated Platelet in Patients With Non-ST-segment-elevation Acute Coronary Syndromes

Inhibitory Effect of Clopidogrel on Release of Soluble CD40 Ligand by ADP-activated Platelet in Patients With Non-ST-segment-elevation Acute Coronary Syndromes

在线阅读下载PDF 导出详情

摘要未填写

DOI g4q0959zj8/610472

作者 Wei Wei;Chufan Luo;Zhimin Du

机构地区不详

出处《岭南心血管病杂志：英文版》 2008年2期

关键词急性冠状动脉综合症抑制效应血小板血浆

分类 [医药卫生][心血管疾病]

出版日期 2008年02月12日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1Xinxia Zhang, Wen Duan, Wenbin Wei, Bijuan Kuang, Yunqi Zhang, Xiangguang Xu, Xuesong HuDepartment of Cardiology, Shenzhen Futian Hospital Affiliated of Guangdong Medical College,Shenzhen 518033, China. Effect of Clopidogrel on Platelet Membrane CD40 Ligand in Coronary Artery Disease Patients Undertaking Percutaneous Coronary Intervention.心血管疾病,2007-03.
2ZHANG Xiao-hui;ZENG Wei. Prognostic value of combination of ST-segment elevation in lead aVR and positive cTnI in patients with non-ST- segment elevation acute coronary syndrome.心血管疾病,2017-01.
3黄桂锋;杨希立. Latest Advancement of Non ST-segment Elevation Acute Coronary Syndrome.心血管疾病,2008-04.
4禤海燕;罗思妮;刘惠霞. The association between admission systolic blood pressure and 1-year mortality in patients with non-ST-segment elevation acute coronary syndrome.心血管疾病,2017-03.
5Manish Pradhan Shuxian Zhou Juan Lei Zesheng Liu. A Retrospective Clinical Analysis of 216 Patients With Non-ST Segment Elevation Myocardial Infarction.心血管疾病,2008-03.
6Liu Rong,Sun Yu-Qing,Hou Xiao-Xia,Zheng Yang,Huffman Mark D.,Anderson Craig S.,He Liu,Xia Shi-Jun,Jiang Chao,Du Xin,Dong Jian-Zeng,Ma Chang-Sheng. Temporal trends in diagnosis, treatment, and outcome for non-ST-segment elevation acute coronary syndrome in three regions of China, 2008-2015.医药卫生,2021-09.
7张焕基;张新霞;吴剑胜;胡雪松. Clinical benefits of intracoronary high-dose tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.心血管疾病,2010-02.
8CHEN Ming-yu;Hong Wan-zi;YU Yang;JIANG Lei;XIONG Si;LUO Chang-jun. Prognostic value of magnesium in serum of patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.心血管疾病,2018-03.
9LIU De-hui;QIN Zhi-hui. Comparison of different risk scores in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.心血管疾病,2018-02.
10MA Gui-zhou;XU Rong-he;WANG Ying;CHEN Shao-min;NI Chu-min;CAI Zhi-xiong. Contrast-induced nephropathy after staged percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.心血管疾病,2018-03.

来源期刊

岭南心血管病杂志：英文版

岭南心血管病杂志：英文版

相关推荐

同分类资源更多

相关关键词

急性冠状动脉综合症抑制效应血小板血浆

返回顶部